|

Radiotherapy Treatments for the Treatment of Thoracic District Tumors

RECRUITINGSponsored by European Institute of Oncology
Actively Recruiting
SponsorEuropean Institute of Oncology
Started2018-02-22
Est. completion2024-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06335290

Summary

Evaluation of clinical and dosimetric aspects, tolerance, and effectiveness of thoracic radiotherapy treatments in patients undergoing radiotherapy for primary or secondary neoplasms localized in the thoracic anatomical region.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Patients treated with radiotherapy for curative, palliative, neo-adjuvant, and adjuvant purposes in the thoracic region include those with:

   * Primary bone tumors,
   * Primary soft tissue tumors,
   * Primary tumors of the cardio-circulatory system,
   * Primary tumors of the lymphatic system,
   * Primary tumors of the nervous system and skin,
   * Secondary metastases from various origins localized in the thoracic region.
2. Signed informed consent

Exclusion Criteria:

1\. Radiotherapy in districts other than the thoracic region.

Conditions2

CancerThoracic Neoplasms

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.